MedTech Europe’s Position Paper Aims To Smooth Certification Pathway For High-Risk IVDs
Executive Summary
With the deadline for class D high-risk IVDs less than 18 months away and the underpinning regulatory structure still embryonic, MedTech Europe calls for clearer policies to give manufacturers a good chance of overcoming the regulatory challenges in time.